Contact
Please use this form to send email to PR contact of this press release:
Kura Oncology Announces Preliminary Data for Menin Inhibitor KO-539 Accepted for Oral Presentation at ASH
TO:
Please use this form to send email to PR contact of this press release:
Kura Oncology Announces Preliminary Data for Menin Inhibitor KO-539 Accepted for Oral Presentation at ASH
TO: